Filter Results
4 results
- Data for: A phase II, multicenter, single-arm trial of eribulin as first-line therapy for aggressive taxane-pretreated HER2-negative metastatic breast cancer patients: The MERIBEL studyA phase II, multicenter, single-arm trial of eribulin as first-line therapy for aggressive taxane-pretreated HER2-negative metastatic breast cancer patients: The MERIBEL study
- Data for: Risk reduction and survival benefit of risk-reducing salpingo-oophorectomy in hereditary breast cancer: a meta-analysis and systematic reviewthe risk reduction and survival benefit of breast cancer
- Data for: Factors affecting sexual function and body image of early stage breast cancer survivors in Poland: A short-term observation.Date set used for statistical analysis
- Data for: Adherence to adjuvant endocrine therapy in women with breast cancer: a prospective observational study in Japanese womendate of "Adherence to adjuvant endocrine therapy in women with breast cancer: a prospective observational study in Japanese women"